IAS PARIS 2017
We’re allies: the power of partnership
In partnership with IAS, we demonstrate our ongoing commitment to scientific research and clinical development to address some of the ongoing challenges of the HIV epidemic
ViiV Healthcare announces positive results of DAWNING study at IAS
Study shows superior efficacy of dolutegravir in resource limited settings
Dolutegravir regimen study results at International AIDS Society meeting in Paris
Collaborative study of dolutegravir treatment in patients with HIV and high CV risk
Preliminary Positive Perspectives Survey Data Released at IAS 2017
Emotional support and stigma feature as having significant impact on the lives of people living with HIV
ViiV Healthcare Phase 2 study results published in The Lancet
Simultaneous publication and presentation at International AIDS Society meeting in Paris
See you in Paris! ViiV Healthcare @ the International AIDS Society conference
Overview of our activities and data showcase in Paris next week
Establishing a forum to advance collaboration, communication and shared expertise in Implementation Science.
ViiV Healthcare to host inaugural Implementation Science Network Meeting in Paris
ViiV Healthcare to present research data at IAS in Paris
22 abstracts related to HIV treatment and prevention to be presented at major international HIV conference